RhythmAnalytics vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
RhythmAnalytics
by Biofourmis Singapore Pte.
VS
Rhythm360
by RhythmScience

AI Verdict

RhythmAnalytics is an FDA-cleared AI tool specifically for automated interpretation of cardiac arrhythmias from single-lead ECG data, providing clinical decision support. In contrast, Rhythm360 is a broader, integrated platform that unifies cardiac monitoring data from various devices, offering comprehensive insights for hypertension, heart failure, and rhythm management, alongside workflow optimizations like EHR integration and automated billing. While both address aspects of cardiac rhythm, RhythmAnalytics focuses on diagnostic interpretation, whereas Rhythm360 provides an end-to-end management solution for cardiac care.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is highly accurate, AI-powered automated interpretation of cardiac arrhythmias from single-lead ECG data. This tool is ideal for healthcare professionals or integrators seeking a robust API to enhance clinical decision support specifically for arrhythmia detection and detailed ECG analysis within existing systems or workflows. It excels at providing precise, beat-by-beat morphology computation and identifying over 15 types of cardiac arrhythmias.

View RhythmAnalytics →

Choose Rhythm360 if…

Choose Rhythm360 if you require a comprehensive, integrated platform for managing cardiac remote monitoring data across various devices and conditions. This solution is best suited for clinics or health systems aiming to unify data from all major OEMs, reduce alert fatigue through AI-driven triage, and streamline operational workflows including bi-directional EHR integration and automated CPT code documentation for hypertension, heart failure, and rhythm management. It offers a holistic approach to cardiac care, extending beyond just arrhythmia interpretation.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RhythmAnalytics Rhythm360
Pricing Contact vendor Flexible pricing model that scales with clinic size and platform usage.
Deployment Cloud-based API Cloud-based SaaS platform
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

Rhythm360 (Tool B) offers a more comprehensive and user-facing experience with its integrated platform and HIPAA-compliant mobile application for clinicians. Its AI-driven alert triage directly addresses clinician workflow and reduces fatigue, indicating a strong focus on usability. RhythmAnalytics (Tool A) is primarily described as a cloud-based API, suggesting a more backend integration focus rather than direct end-user interaction.

Clinical Value

RhythmAnalytics

RhythmAnalytics (Tool A) holds an FDA clearance for its AI-powered automated interpretation of cardiac arrhythmias from single-lead ECG data, providing a strong, validated clinical decision support. While Rhythm360 (Tool B) offers actionable insights for hypertension, heart failure, and rhythm management, it does not explicitly state FDA clearance for its AI components, making Tool A's clinical validation more concrete for its specific diagnostic function.

Pricing & Value

Rhythm360

Rhythm360 (Tool B) provides more transparency with a 'flexible pricing model that scales with clinic size and platform usage,' even if it's noted as 'premium pricing.' This allows potential customers to understand the cost structure and assess value based on their needs. RhythmAnalytics (Tool A) only states 'contact vendor,' offering no immediate insight into its pricing or value proposition.

Enterprise Readiness

Rhythm360

Rhythm360 (Tool B) demonstrates superior enterprise readiness through its vendor-neutral data aggregation from major OEMs and bi-directional EHR integration with leading systems like Epic and Cerner. Additionally, its automated CPT code documentation and billing, along with robust AI Data Normalization capabilities, streamline complex enterprise workflows. RhythmAnalytics (Tool A) offers cloud-based API integration and compatibility with FDA-cleared ECG devices, but lacks the extensive integration and workflow automation features of Tool B.

Innovation

Rhythm360

Rhythm360 (Tool B) showcases broader innovation by unifying diverse cardiac monitoring data, applying AI for alert triage to reduce clinician fatigue, and utilizing predictive algorithms for heart failure management. Its AI Data Normalization, including PDF parsing via computer vision, highlights advanced data handling. While RhythmAnalytics (Tool A) is innovative in its FDA-cleared, deep AI interpretation of ECGs, Tool B's comprehensive platform approach addresses a wider range of systemic challenges in cardiac care.

Support & Docs

Rhythm360

Rhythm360 (Tool B) explicitly offers 'Optional 24/7/365 oversight by certified cardiac technicians (CCTs),' indicating a robust and continuous support structure for its users. RhythmAnalytics (Tool A) does not provide any information regarding its support offerings or documentation, making it impossible to assess this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RhythmAnalytics Rhythm360
Primary Use Case Automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support. Unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
Company Biofourmis Singapore Pte. RhythmScience
Core AI Focus AI-based automated interpretation of cardiac arrhythmias (over 15 types), beat-by-beat morphology computation, ECG signal processing and analysis. AI-driven alert triage, AI Data Normalization (API, HL7, XML, PDF parsing via computer vision), predictive algorithms for Heart Failure Management.
Data Source Compatibility Compatibility with FDA-cleared ECG devices (Holter, event recorders, wearable sensors). Vendor-neutral data aggregation (all major OEMs: Medtronic, Boston Scientific, Abbott, Biotronik).
EHR Integration Not specified Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity).
Additional Differentiating Features Not specified Automated CPT code documentation and billing, HIPAA-compliant mobile application for clinicians, optional 24/7/365 oversight by certified cardiac technicians (CCTs).

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and Rhythm360.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

RhythmAnalytics is an FDA-cleared, AI-powered cloud-based software specifically for automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support. In contrast, Rhythm360 is an AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and aims to reduce alert fatigue.
RhythmAnalytics is compatible with FDA-cleared ECG devices such as Holter monitors, event recorders, or wearable sensors, and processes single-lead ECG data via a cloud-based API. Rhythm360 offers vendor-neutral data aggregation from all major OEMs, including Medtronic, Boston Scientific, Abbott, and Biotronik, and supports various data formats like API, HL7, XML, and PDF parsing via computer vision.
Rhythm360 provides features for heart failure management, including predictive algorithms and GDMT optimization, as well as automated CPT code documentation and billing for codes like 93298, 93299, 99454, and 99453. RhythmAnalytics focuses on the AI-based automated interpretation and detection of over 15 types of cardiac arrhythmias.
RhythmAnalytics is explicitly FDA-cleared for its AI-powered automated interpretation of cardiac arrhythmias and is HIPAA compliant. Rhythm360 is HIPAA-compliant and specifies having a Business Associate Agreement (BAA), but its description does not mention FDA clearance for the platform itself.
RhythmAnalytics offers a cloud-based API for integration with compatible FDA-cleared ECG devices. Rhythm360 provides bi-directional EHR integration with major systems like Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, and GE Centricity, and can automate CPT code documentation within EHR workflows.
Rhythm360 offers optional 24/7/365 oversight by certified cardiac technicians (CCTs) as part of its service. RhythmAnalytics focuses on providing AI-based automated interpretation of ECG data for clinical decision support.
RhythmAnalytics is designed for Cardiology, Emergency Medicine, and Internal Medicine. Rhythm360 is specifically tailored for Cardiology.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring RhythmAnalytics or Rhythm360

AI Tool Finder
AI-powered search. Results may not be comprehensive.